心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2022 TASTRO/TSOC共识声明：放射性心血管疾病的风险管理

2022-01-20 台湾心脏病学会 Acta Cardiol Sin

风险管理放射性心血管疾病

癌症管理的不断进步显著提高了癌症患者的生存率，在癌症的放射治疗过程中对心血管的辐射已被认为是心血管疾病的一个新的危险因素。本文主要介绍了放射性心血管疾病的风险分层和临床管理实践指导。

中文标题：

2022 TASTRO/TSOC共识声明：放射性心血管疾病的风险管理

英文标题：

Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC)

发布机构：

台湾心脏病学会

发布日期：

2022-01-20

简要介绍：

癌症管理的不断进步显著提高了癌症患者的生存率，在癌症的放射治疗过程中对心血管的辐射已被认为是心血管疾病的一个新的危险因素。本文主要介绍了放射性心血管疾病的风险分层和临床管理实践指导。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 TASTRO／TSOC共识声明：放射性心血管疾病的风险管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=2884b1c0023395a4, title=2022 TASTRO/TSOC共识声明：放射性心血管疾病的风险管理, enTitle=Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC), guiderFrom=Acta Cardiol Sin, authorId=0, author=, summary=癌症管理的不断进步显著提高了癌症患者的生存率，在癌症的放射治疗过程中对心血管的辐射已被认为是心血管疾病的一个新的危险因素。本文主要介绍了放射性心血管疾病的风险分层和临床管理实践指导。, cover=https://img.medsci.cn/2022125/1643110324011_1608702.png, journalId=0, articlesId=null, associationId=267, associationName=台湾心脏病学会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Jan 20 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">癌症管理的不断进步显著提高了癌症患者的生存率，在癌症的放射治疗过程中对心血管的辐射已被认为是心血管疾病的一个新的危险因素。本文主要介绍了放射性心血管疾病的风险分层和临床管理实践指导。</span></p>, tagList=[TagDto(tagId=771, tagName=风险管理), TagDto(tagId=122203, tagName=放射性心血管疾病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3733, appHits=71, showAppHits=0, pcHits=316, showPcHits=3662, likes=1, shares=20, comments=3, approvalStatus=1, publishedTime=Wed Jan 26 15:30:00 CST 2022, publishedTimeString=2022-01-20, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=6, createdBy=null, createdName=dajiong, createdTime=Tue Jan 25 19:36:26 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 05:55:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 TASTRO／TSOC共识声明：放射性心血管疾病的风险管理.pdf)])
2022 TASTRO／TSOC共识声明：放射性心血管疾病的风险管理.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1193890, encodeId=c3331193890e7, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Wed Feb 16 08:52:45 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192326, encodeId=9ad4119232661, content=关注放射性心脏疾病，提高生活质量, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8615567871, createdName=ms7000000269716353, createdTime=Fri Feb 11 14:23:07 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188658, encodeId=29ff1188658f4, content=放射性心血管疾病值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8de6465631, createdName=ms7000000671946062, createdTime=Thu Jan 27 20:22:34 CST 2022, time=2022-01-27, status=1, ipAttribution=)]
    2022-02-16 龙珠

    学习好资料

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1193890, encodeId=c3331193890e7, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Wed Feb 16 08:52:45 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192326, encodeId=9ad4119232661, content=关注放射性心脏疾病，提高生活质量, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8615567871, createdName=ms7000000269716353, createdTime=Fri Feb 11 14:23:07 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188658, encodeId=29ff1188658f4, content=放射性心血管疾病值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8de6465631, createdName=ms7000000671946062, createdTime=Thu Jan 27 20:22:34 CST 2022, time=2022-01-27, status=1, ipAttribution=)]
    2022-02-11 ms7000000269716353

    关注放射性心脏疾病，提高生活质量

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1193890, encodeId=c3331193890e7, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Wed Feb 16 08:52:45 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192326, encodeId=9ad4119232661, content=关注放射性心脏疾病，提高生活质量, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8615567871, createdName=ms7000000269716353, createdTime=Fri Feb 11 14:23:07 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188658, encodeId=29ff1188658f4, content=放射性心血管疾病值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8de6465631, createdName=ms7000000671946062, createdTime=Thu Jan 27 20:22:34 CST 2022, time=2022-01-27, status=1, ipAttribution=)]
    2022-01-27 ms7000000671946062

    放射性心血管疾病值得关注

    0

相关指南

2019 国际共识：接受SGLT抑制剂治疗的1型糖尿病患者糖尿病酸中毒风险管理

国外内分泌相关专家小组（统称） · 2019-02-06